A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

Authors: Cortese, Matthew J., Wei, Wei, Cerdeña, Sebastian, Watkins, Marcus P., Olson, Marissa, Jodon, Gray, Kaiser, Jeff, Haverkos, Bradley, Hughes, Mitchell E., Namoglu, Esin, Grover, Natalie S., Snow, Anson, Orellana-Noia, Victor, Rainey, Magdalena, Sohail, Mohammad, Rudoni, Joslyn, Portell, Craig, Voorhees, Timothy, Landsburg, Daniel J., Kamdar, Manali, Kahl, Brad S., Hill, Brian T.

Source: Leukemia & lymphoma. 64(1):107-118

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178760291.0x000001&indx=1&recIds=ETOCvdc_100178760291.0x000001

Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study

Authors: Hess, Brian T., Giri, Anshu, Park, Yeonhee, Patel, Krina K., Link, Brian K., Nowakowski, Grzegorz S., Maliske, Seth M., Fortin, Sonia, Chavez, Julio C., Saeed, Hayder, Hill, Brian T., Mejia Garcia, Alex V., Maddocks, Kami J., Hanel, Walter, Wagner‐Johnston, Nina D., Messmer, Marcus R., Kahl, Brad S., Watkins, Marcus, Alderuccio, Juan Pablo, Lossos, Izidore S., Nathan, Sunita, Orellana‐Noia, Victor M., Portell, Craig A., Landsburg, Daniel J., Ayers, Emily C., Castillo, Jorge J.

Source: American journal of hematology. 98(2):300-308

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100170803971.0x000001&indx=1&recIds=ETOCvdc_100170803971.0x000001

Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?

Authors: Lantz, Jeffrey, Portell, Craig A., Ayers, Emily C.

Source: In Blood Reviews September 2023 61

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Authors: Sawalha, Yazeed, Goyal, Subir, Switchenko, Jeffrey M., Romancik, Jason T., Kamdar, Manali, Greenwell, I. Brian, Hess, Brian T., Isaac, Krista M., Portell, Craig A., Mejia Garcia, Alex, Goldsmith, Scott, Grover, Natalie S., Riedell, Peter A., Karmali, Reem, Burkart, Madelyn, Buege, Michael, Akhtar, Othman, Torka, Pallawi, Kumar, Anita, Hill, Brian T., Kahl, Brad S., Cohen, Jonathon B.

Source: In Blood Advances 11 July 2023 7(13):2983-2993

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Authors: Orellana-Noia, Victor Manuel, Reed, Daniel R., McCook, Ashley Alesia, Sen, Jeremy Michael, Barlow, Christian M., Malecek, Mary-Kate, Watkins, Marcus, Kahl, Brad S., Spinner, Michael A., Advani, Ranjana, Voorhees, Timothy J., Snow, Anson, Grover, Natalie Sophia, Ayers, Amy, Romancik, Jason, Liu, Yuxin, Huntington, Scott F., Chavez, Julio C., Saeed, Hayder, Lazaryan, Aleksandr, Raghunathan, Vikram, Spurgeon, Stephen E., Ollila, Thomas A., Del Prete, Christopher, Olszewski, Adam, Ayers, Emily C., Landsburg, Daniel J., Echalier, Benjamin, Lee, Jun, Kamdar, Manali, Caimi, Paolo F., Fu, Timothy, Liu, Jieqi, David, Kevin A., Alharthy, Hanan, Law, Jennie, Karmali, Reem, Shah, Harsh, Stephens, Deborah M., Major, Ajay, Rojek, Alexandra E., Smith, Sonali M., Yellala, Amulya, Kallam, Avyakta, Nakhoda, Shazi, Khan, Nadia, Sohail, Mohammad Ahsan, Hill, Brian T., Barrett-Campbell, Odeth, Lansigan, Frederick, Switchenko, Jeffrey, Cohen, Jonathon, Portell, Craig A.

Source: Blood. 139(3):413-423

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183242284.0x000001&indx=1&recIds=ETOCvdc_100183242284.0x000001

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma

Authors: Portell, Craig A. ^*, Wages, Nolan A., Kahl, Brad S., Budde, Lihua E., Chen, Robert W., Cohen, Jonathon B., Varhegyi, Nikole E., Petroni, Gina R., Williams, Michael E.

Source: In Blood Advances 8 March 2022 6(5):1490-1498

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Authors: Roeker, Lindsey E. ^{1, *}, Eyre, Toby A. ^{2, *}, Thompson, Meghan C. ¹, Lamanna, Nicole ³, Coltoff, Alexander R. ³, Davids, Matthew S. ⁴, Baker, Peter O. ⁴, Leslie, Lori ⁵, Rogers, Kerry A. ⁶, Allan, John N. ⁷, Cordoba, Raul ⁸, Lopez-Garcia, Alberto ⁸, Antic, Darko ⁹, Pagel, John M. ¹⁰, Martinez-Calle, Nicolas ¹¹, García-Marco, José Antonio ¹², Hernández‐Rivas, Jose‐Ángel ¹³, Miras, Fatima ¹⁴, Coombs, Catherine C. ¹⁵, Österborg, Anders ¹⁶, Hansson, Lotta ¹⁶, Seddon, Amanda N. ¹⁷, López Jiménez, Javier ¹⁸, Wilson, Matthew R. ¹⁹, El-Sharkawi, Dima ²⁰, Wojenski, Daniel ²¹, Ma, Shuo ²¹, Munir, Talha ²², Valenciano, Susana ²³, Seymour, Erlene ²⁴, Barr, Paul M. ²⁵, Pu, Jeffrey ²⁶, Patten, Piers E.M. ²⁷, Perini, Guilherme F. ²⁸, Huntington, Scott F. ²⁹, Parry, Helen ³⁰, Sundaram, Suchitra ³¹, Skarbnik, Alan ³², Kamdar, Manali ³³, Jacobs, Ryan ³⁴, Walter, Harriet ³⁵, Walewska, Renata ³⁶, Broom, Angus ³⁷, Lebowitz, Sonia ¹, Isaac, Krista M. ³⁸, Portell, Craig A. ³⁸, Ahn, Inhye E. ³⁹, Ujjani, Chaitra S. ⁴⁰, Shadman, Mazyar ⁴⁰, Skånland, Sigrid S. ⁴¹, Chong, Elise A. ⁴², Mato, Anthony R. ^{1, *}

Source: In Blood 4 November 2021 138(18):1768-1773

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Authors: Orellana-Noia, Victor M. ^*, Isaac, Krista, Malecek, Mary-Kate, Bartlett, Nancy L., Voorhees, Timothy J., Grover, Natalie S., Hwang, Steven R., Bennani, N. Nora, Hu, Rachel, Hill, Brian T., Mou, Eric, Advani, Ranjana H., Carter, Jordan, David, Kevin A., Ballard, Hatcher J., Svoboda, Jakub, Churnetski, Michael C., Magarelli, Gabriela, Feldman, Tatyana A., Cohen, Jonathon B., Evens, Andrew M., Portell, Craig A.

Source: In Blood Advances 28 September 2021 5(18):3623-3632

Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL

Authors: Jayappa, Kallesh D., Gordon, Vicki L., Morris, Christopher G., Wilson, Briana, Shetty, B. Dharmaveer, Cios, Konrad J., Arora, Puja C., Isaac, Krista M., Saha, Shekhar, Bender, Timothy P. ^*, Williams, Michael E., Portell, Craig A., Weber, Michael J.

Source: In Blood Advances 14 September 2021 5(17):3497-3510

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Authors: Alderuccio, Juan Pablo ^{*, *}, Olszewski, Adam J. ^*, Evens, Andrew M. ^*, Collins, Graham P., Danilov, Alexey V., Bower, Mark, Jagadeesh, Deepa, Zhu, Catherine, Sperling, Amy, Kim, Seo-Hyun, Vaca, Ryan, Wei, Catherine, Sundaram, Suchitra, Reddy, Nishitha, Dalla Pria, Alessia, D'Angelo, Christopher, Farooq, Umar, Bond, David A., Berg, Stephanie, Churnetski, Michael C., Godara, Amandeep, Khan, Nadia, Choi, Yun Kyong, Kassam, Shireen, Yazdy, Maryam, Rabinovich, Emma, Post, Frank A., Varma, Gaurav, Karmali, Reem, Burkart, Madelyn, Martin, Peter, Ren, Albert, Chauhan, Ayushi, Diefenbach, Catherine, Straker-Edwards, Allandria, Klein, Andreas, Blum, Kristie A., Boughan, Kirsten Marie, Mian, Agrima, Haverkos, Bradley M., Orellana-Noia, Victor M., Kenkre, Vaishalee P., Zayac, Adam, Maliske, Seth M., Epperla, Narendranath, Caimi, Paolo, Smith, Scott E., Kamdar, Manali, Venugopal, Parameswaran, Feldman, Tatyana A., Rector, Daniel, Smith, Stephen D., Stadnik, Andrzej, Portell, Craig A., Lin, Yong, Naik, Seema, Montoto, Silvia, Lossos, Izidore S., Cwynarski, Kate

Source: In Blood Advances 27 July 2021 5(14):2852-2862

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Authors: Evens, Andrew M. ^*, Danilov, Alexey, Jagadeesh, Deepa, Sperling, Amy, Kim, Seo-Hyun, Vaca, Ryan, Wei, Catherine, Rector, Daniel, Sundaram, Suchitra, Reddy, Nishitha, Lin, Yong, Farooq, Umar, D'Angelo, Christopher, Bond, David A., Berg, Stephanie, Churnetski, Michael C., Godara, Amandeep, Khan, Nadia, Choi, Yun Kyong, Yazdy, Maryam, Rabinovich, Emma, Varma, Gaurav, Karmali, Reem, Mian, Agrima, Savani, Malvi, Burkart, Madelyn, Martin, Peter, Ren, Albert, Chauhan, Ayushi, Diefenbach, Catherine, Straker-Edwards, Allandria, Klein, Andreas K., Blum, Kristie A., Boughan, Kirsten Marie, Smith, Scott E., Haverkos, Brad M., Orellana-Noia, Victor M., Kenkre, Vaishalee P., Zayac, Adam, Ramdial, Jeremy, Maliske, Seth M., Epperla, Narendranath, Venugopal, Parameswaran, Feldman, Tatyana A., Smith, Stephen D., Stadnik, Andrzej, David, Kevin A., Naik, Seema, Lossos, Izidore S., Lunning, Matthew A., Caimi, Paolo, Kamdar, Manali, Palmisiano, Neil, Bachanova, Veronika, Portell, Craig A., Phillips, Tycel, Olszewski, Adam J. ^*, Alderuccio, Juan Pablo ^*

Source: In Blood 21 January 2021 137(3):374-386

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Authors: Mato, Anthony R. ^{1, 1, *}, Roeker, Lindsey E. ^{1, *}, Lamanna, Nicole ², Allan, John N. ³, Leslie, Lori ⁴, Pagel, John M. ⁵, Patel, Krish ⁵, Osterborg, Anders ⁶, Wojenski, Daniel ⁷, Kamdar, Manali ⁸, Huntington, Scott F. ⁹, Davids, Matthew S. ¹⁰, Brown, Jennifer R. ¹⁰, Antic, Darko ¹¹, Jacobs, Ryan ¹², Ahn, Inhye E. ¹³, Pu, Jeffrey ¹⁴, Isaac, Krista M. ¹⁵, Barr, Paul M. ¹⁶, Ujjani, Chaitra S. ¹⁷, Geyer, Mark B. ¹, Berman, Ellin ¹, Zelenetz, Andrew D. ¹, Malakhov, Nikita ³, Furman, Richard R. ³, Koropsak, Michael ⁴, Bailey, Neil ⁵, Hanson, Lotta ⁶, Perini, Guilherme F. ¹⁸, Ma, Shuo ⁷, Ryan, Christine E. ¹⁰, Wiestner, Adrian ¹³, Portell, Craig A. ¹⁵, Shadman, Mazyar ¹⁷, Chong, Elise A. ¹⁹, Brander, Danielle M. ²⁰, Sundaram, Suchitra ²¹, Seddon, Amanda N. ²², Seymour, Erlene ²³, Patel, Meera ²³, Martinez-Calle, Nicolas ²⁴, Munir, Talha ²⁵, Walewska, Renata ²⁶, Broom, Angus ²⁷, Walter, Harriet ²⁸, El-Sharkawi, Dima ²⁹, Parry, Helen ³⁰, Wilson, Matthew R. ³¹, Patten, Piers E.M. ³², Hernández-Rivas, José-Ángel ³³, Miras, Fatima ³⁴, Fernández Escalada, Noemi ³⁵, Ghione, Paola ¹, Nabhan, Chadi ³⁶, Lebowitz, Sonia ¹, Bhavsar, Erica ³, López-Jiménez, Javier ³⁷, Naya, Daniel ³⁸, Garcia-Marco, Jose Antonio ³⁹, Skånland, Sigrid S. ⁴⁰, Cordoba, Raul ⁴¹, Eyre, Toby A. ⁴²

Source: In Blood 3 September 2020 136(10):1134-1143

Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure

Authors: Ayers, Emily C., Li, Shaoying, Medeiros, L. Jeffrey, Bond, David A., Maddocks, Kami J., Torka, Pallawi, Mier Hicks, Angel, Curry, Madeira, Wagner‐Johnston, Nina D., Karmali, Reem, Behdad, Amir, Fakhri, Bita, Kahl, Brad S., Churnetski, Michael C., Cohen, Jonathon B., Reddy, Nishitha M., Modi, Dipenkumar, Ramchandren, Radhakrishnan, Howlett, Christina, Leslie, Lori A., Cytryn, Samuel, Diefenbach, Catherine S., Faramand, Rawan, Chavez, Julio C., Olszewski, Adam J., Liu, Yang, Barta, Stefan K., Mukhija, Dhruvika, Hill, Brian T., Ma, Helen, Amengual, Jennifer E., Nathan, Sunita, Assouline, Sarit E., Orellana‐Noia, Victor M., Portell, Craig A., Chandar, Ashwin, David, Kevin A., Giri, Anshu, Hess, Brian T., Landsburg, Daniel J.

Source: Cancer. 126(2):293-303

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097872449.0x000001&indx=1&recIds=ETOCvdc_100097872449.0x000001

An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract

Authors: Krishnan, Rahul, Ring, Kari, Williams, Eli, Portell, Craig, Jaffe, Elaine S., Gru, Alejandro A.

Source: American journal of surgical pathology. 44(4):561-565

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100102391047.0x000001&indx=1&recIds=ETOCvdc_100102391047.0x000001

ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas

Authors: Orellana-Noia, Victor ¹, Reed, Daniel ², McCook, Ashley ¹, Sen, Jeremy ³, Barlow, Christian ³, Malecek, Mary-Kate ⁴, Watkins, Marcus ⁴, Kahl, Brad ⁴, Spinner, Michael ⁵, Advani, Ranjana ⁵, Voorhees, Timothy ⁶, Snow, Anson ⁶, Grover, Natalie ⁶, Ayers, Amy ¹, Romancik, Jason ¹, Liu, Yuxin ⁷, Huntington, Scott ⁷, Chavez, Julio ⁸, Saeed, Hayder ⁸, Lazaryan, Aleksandr ⁸, Raghunathan, Vikram ⁹, Spurgeon, Stephen ¹⁰, Ollila, Thomas ¹¹, Prete, Christopher Del ¹¹, Olszewski, Adam ¹¹, Ayers, Emily ³, Landsburg, Daniel ¹², Echalier, Benjamin ¹³, Lee, Jun ¹³, Kamdar, Manali ¹³, Calmi, Paolo ¹⁴, Fu, Timothy ¹⁵, Liu, Jieqi ¹⁵, David, Kevin ¹⁵, Alharthy, Hanan ¹⁶, Law, Jennie ¹⁶, Karmali, Reem ¹⁷, Shah, Harsh ¹⁸, Stephens, Deborah ¹⁸, Major, Ajay ¹⁹, Rojek, Alexandra ¹⁹, Smith, Sonali ¹⁹, Yellala, Amulya ²⁰, Kallam, Ayvakta ²⁰, Nakhoda, Shazia ²¹, Khan, Nadia ²¹, Sohail, Mohammad ¹⁴, Hill, Brian ¹⁴, Barrett-Campbell, Odeth ²², Lansigan, Frederick ²², Switchenko, Jeffrey ¹, Cohen, Jonathon ¹, Portell, Craig ³

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S381-S381

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Authors: Flinn, Ian W. ^*, Hillmen, Peter, Montillo, Marco, Nagy, Zsolt, Illés, Árpád, Etienne, Gabriel, Delgado, Julio, Kuss, Bryone J., Tam, Constantine S., Gasztonyi, Zoltán, Offner, Fritz, Lunin, Scott, Bosch, Francesco, Davids, Matthew S., Lamanna, Nicole, Jaeger, Ulrich, Ghia, Paolo, Cymbalista, Florence, Portell, Craig A., Skarbnik, Alan P., Cashen, Amanda F., Weaver, David T., Kelly, Virginia M., Turnbull, Barry, Stilgenbauer, Stephan

Source: In Blood 6 December 2018 132(23):2446-2455

Risk of Major Bleeding with Ibrutinib

Authors: Mock, Joseph, Kunk, Paul R., Palkimas, Surabhi, Sen, Jeremy M., Devitt, Michael, Horton, Bethany, Portell, Craig A., Williams, Michael E., Maitland, Hillary

Source: In Clinical Lymphoma, Myeloma and Leukemia November 2018 18(11):755-761

Novel therapies for relapsed/refractory mantle cell lymphoma

Authors: Arora, Puja C., Portell, Craig A.

Source: In Best Practice & Research Clinical Haematology March 2018 31(1):105-113

Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial

Authors: Opat, Stephen, Tedeschi, Alessandra, Hu, Bei, Linton, Kim M, McKay, Pamela, Chan, Henry, Jin, Jie, Sun, Mingyuan, Sobieraj-Teague, Magdalena, Zinzani, Pier Luigi, Browett, Peter, Ke, Xiaoyan, Portell, Craig A., Thieblemont, Catherine, Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Ho, Shir-Jing, Zhou, Keshu, Liang, Zhiyu, Xu, Jianfeng, Tankersley, Chris, Delarue, Richard, Co, Melannie, Trotman, Judith

Source: Transplantation and Cellular Therapy. 29(S):S105-S106

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100180674877.0x000001&indx=1&recIds=ETOCvdc_100180674877.0x000001

Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

Authors: Hill, Brian T., Nastoupil, Loretta, Winter, Allison M., Becnel, Melody R., Cerhan, James R., Habermann, Thomas M., Link, Brian K., Maurer, Matthew J., Fakhri, Bita, Reddy, Prathima, Smith, Stephen D., Mukhija, Dhruvika, Jagadeesh, Deepa, Desai, Amrita, Alderuccio, Juan Pablo, Lossos, Izidore S., Mehra, Pooja, Portell, Craig A., Goldman, Max L., Calzada, Oscar, Cohen, Jonathon B., Hussain, Mohammad J., Ghosh, Nilanjan, Caimi, Paolo, Tiutan, Timothy, Martin, Peter, Kodali, Abhigna, Evens, Andrew M., Kahl, Brad S.

Source: British journal of haematology. 184(4):524-535

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100085009217.0x000001&indx=1&recIds=ETOCvdc_100085009217.0x000001